THR - Madrigal wins FDA approval for NASH therapy
2024-03-14 15:45:17 ET
More on Madrigal Pharmaceuticals
- Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown
- Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade)
- Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potential
- Madrigal and liver drug developers fall ahead of FDA decision on NASH therapy
- Liver drug developers outperform as U.S. awaits first NASH drug